Abstract
Industrial BiotechnologyVol. 5, No. 3 FEATURE COMMENTARYDescription proscription? Ariad v. Lilly decision to be reviewed by full courtGwilym J.O. Attwell, Lauren Murphy Pringle, and Michael M. RosenGwilym J.O. AttwellSearch for more papers by this author, Lauren Murphy PringleSearch for more papers by this author, and Michael M. RosenSearch for more papers by this authorPublished Online:1 Oct 2009https://doi.org/10.1089/ind.2009.3.174AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail "Description proscription? Ariad v. Lilly decision to be reviewed by full court." , 5(3), pp. 174–175FiguresReferencesRelatedDetailsCited byUpdating industrial biotech patent strategies: Practical advice in light of recent case history R. Brian McCaslin22 February 2010 | Industrial Biotechnology, Vol. 6, No. 1 Volume 5Issue 3Sep 2009 InformationCopyright 2009, Gen Publishing Inc., Mary Ann Liebert, Inc.To cite this article:Gwilym J.O. Attwell, Lauren Murphy Pringle, and Michael M. Rosen.Description proscription? Ariad v. Lilly decision to be reviewed by full court.Industrial Biotechnology.Sep 2009.174-175.http://doi.org/10.1089/ind.2009.3.174Published in Volume: 5 Issue 3: October 1, 2009PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
